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ABSTRACT
RNA aptamers against bovine prion protein (bPrP)
were obtained, most of the obtained aptamers
being found to contain the r(GGAGGAGGAGGA)
(R12) sequence. Then, it was revealed that R12
binds to both bPrP and its b-isoform with high
affinity. Here, we present the structure of R12. This
is the first report on the structure of an RNA aptamer
against prion protein. R12 forms an intramolecular
parallel quadruplex. The quadruplex contains
G:G:G:G tetrad and G(:A):G:G(:A):G hexad planes.
Two quadruplexes form a dimer through inter-
molecular hexad–hexad stacking. Two lysine
clusters of bPrP have been identified as binding
sites for R12. The electrostatic interaction between
the uniquely arranged phosphate groups of R12 and
the lysine clusters is suggested to be responsible
for the affinity of R12 to bPrP. The stacking
interaction between the G:G:G:G tetrad planes and
tryptophan residues may also contribute to the
affinity. One R12 dimer molecule is supposed to
simultaneously bind the two lysine clusters of one
bPrP molecule, resulting in even higher affinity.
The atomic coordinates of R12 would be useful for
the development of R12 as a therapeutic agent
against prion diseases and Alzheimer’s disease.
INTRODUCTION
Prions are infectious particles and are composed exclu-
sively of misfolded proteins, being devoid of nucleic
acids. The prion protein (PrP) exhibits two forms; a
normal cellular form (PrP
C), which is a soluble a-helix-
rich form, and an abnormal form (PrP
Sc), which is an
insoluble b-sheet-rich form. PrP
C is almost ubiquitously
expressed and highly conserved in mammals, being
anchored on the surface of cells. The conformational
change from PrP
C to PrP
Sc is thought to be crucial in
prion pathogenesis, causing diseases such as a
Creutzfeldt–Jacob disease (CJD) in humans, bovine
spongiform encephalopathy (BSE) in cattle and scrapie in
sheep(1–3).The detailedmechanism oftheconformational
conversion remains unknown.
Speciﬁc-anti-PrP probes, which exhibit high speciﬁcity
and sensitivity, are required for the diagnosis of prion
diseases. Study on the binding of these probes with PrP
would facilitate elucidation of the mechanism of the con-
formational conversion. Furthermore, these probes may
be utilized for therapeutic purposes. An RNA aptamer is
an RNA molecule that can bind a target with high aﬃnity
and speciﬁcity like an antibody does. It was reported that
some aptamer can signiﬁcantly reduce PrP
Sc formation,
which suggests the utility of an RNA aptamer as a thera-
peutic tool against prion diseases (4).
It was reported very recently that PrP
C is a receptor of
amyloid-b-oligomers (5). The accumulation of insoluble
plaque containing the amyloid-b peptide is a pathological
hallmark of Alzheimer’s disease. Preﬁbrillar, soluble
oligomers of amyloid-b have been recognized to be early
and key intermediates in Alzheimer’s-disease-related
synaptic dysfunction (6–9). The amyloid-b-oligomers
have been found to bind to PrP
C (5). The interaction
does not require the PrP
Sc conformation. The blockade
of long-term potentiation by amyloid-b oligomers is
absent in hippocampal slices from adult PrP null mice.
Thus, PrP
C is suggested to be a mediator of amyloid-b
oligomer-induced synaptic dysfunction. It has been
found that anti-PrP antibodies prevent amyloid-b
oligomer binding to PrP
C and rescue synaptic plasticity
in hippocampal slices from oligomeric amyloid-b (5).
This implies that PrP
C-speciﬁc pharmaceutics may have
therapeutic potential against Alzheimer’s disease. There-
fore, an RNA aptamer against PrP may also function as a
therapeutic agent against Alzheimer’s disease.
RNA aptamers against a bovine prion protein (bPrP)
were obtained by means of an in vitro selection method
(10,11) from RNA pools containing a 55-nt randomized
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aﬃnity to both bPrP and its amyloidogenic b isoform
(bPrP-b). It is well established that bPrP-b resembles
PrP
Sc in terms of structural and biochemical properties
(13). It was demonstrated that the RNA aptamer can
speciﬁcally detect PrP
C in a bovine brain homogenate on
northwestern blotting assay (12). This detection has been
conventionally accomplished with an immunoblotting
assay involving an antibody. These RNA aptamers each
comprise a four tandem repeat of the r(GGA) sequence,
r(GGAGGAGGAGGA). Mutagenic studies indicated
that the four tandem repeat is critical for speciﬁc binding
of bPrP and bPrP-b. It was further demonstrated that the
r(GGAGGAGGAGGA) molecule (R12) can bind bPrP
and bPrP-b with high aﬃnity, the dissociation constants
being 8.5 and 280nM, respectively (12). The DNA coun-
terpart molecule, d(GGAGGAGGAGGA) (D12), can
also bind bPrP, but the aﬃnity is weaker by one order.
The aﬃnity of D12 to bPrP-b is also weaker than that of
R12 (12).
It was shown that DNAs containing a repeat of the
d(GGA) sequence form unique quadruplex structures.
Four d(GGAGGA) strands form a quadruplex dimer
composed of two G:G:G:G tetrad planes and two
G(:A):G:G(:A):G hexad ones (14). Two d(GGAGGAG
GAGGA) strands form a quadruplex dimer composed
of two G:G:G:G tetrad planes and two G(:A):G(:A):
G(:A):G heptad ones (15). One d(GGAGGAGGAGGA
GGAGGAGGAGGA) strand forms a unimolecular
quadruplex structure composed of two G:G:G:G tetrad
planes and two G(:A):G(:A):G(:A):G heptad ones (16).
It was also shown that two r(GGAGGUUUUGGAGG)
strands form a quadruplex dimer composed of two
G:G:G:G tetrad planes and two G(:A):G:G(:A):G hexad
ones (17). These studies suggest that the four tandem
repeat of the r(GGA) sequence present in RNA aptamers
also forms a unique quadruplex structure. In fact, the for-
mation of a quadruplex structure was suggested for R12
on the basis of its CD spectrum (12), although the detailed
structure has not been elucidated. The unique quadruplex
structure may be critically utilized for the recognition
of bPrP and bPrP-b by these aptamers. Here, we have
determined the structure of R12 by nuclear magnetic
resonance (NMR). One R12 molecule forms a parallel
quadruplex with a G:G:G:G tetrad plane and a
G(:A):G:G(:A):G hexad one. Then, two R12 quad-
ruplexes form a dimer in a tail-to-tail manner through
hexad–hexad stacking. The R12 structure shares several
common features with the structure formed by the DNA
counterpart molecule, d(GGAGGAGGAGGA) (D12).
Remarkable diﬀerences between the R12 and D12
structures have also been noted. The binding of R12 to
a series of peptide fragments of bPrP was examined by
means of microchip electrophoresis (ME), and two lysine
clusters of bPrP were identiﬁed as binding sites. The
combination of elucidation of the R12 structure and
identiﬁcation of binding sites has suggested that the
aﬃnity of R12 to bPrP is brought about by electrostatic
and stacking interactions. One R12 dimer molecule may
simultaneously bind the two lysine clusters of one
bPrP molecule, which would increase the aﬃnity further.
The origin of the more preferable binding of R12 to
bPrP
C than to bPrP-b has been discussed. The
potential of R12 as a starting molecule for therapeutic
agents against prion diseases and Alzheimer’s disease is
addressed.
MATERIALS AND METHODS
Sample preparation and NMR spectroscopy
An RNA 12-mer (R12), r(GGAGGAGGAGGA), synthe-
sized and puriﬁed by HPLC, was purchased (Nippon
Seihun). R12 was dissolved in a solution comprising
100mM KCl, 10mM K-phosphate (pH 6.2) and 3mM
NaN3. The R12 concentration was 1.0mM. DSS was
used as an internal chemical shift reference. The sample
was heated at 958C for 5min, followed by gradual cooling
to room temperature prior to the measurements.
NMR spectra were recorded at 5 and 308C with Bruker
DRX600 and DRX800 spectrometers equipped with a
cryoprobe with a Z-gradient. The following NMR experi-
ments were performed to assign the resonances, and to
obtain distance and dihedral angle constraints: NOESY,
TOCSY, DQF-COSY,
1H-
13C HSQC and JRHMBC (18).
Spectra were processed and analyzed with XWIN-NMR/
TopSpin (Bruker), NMRPipe (19), Capp/Pipp/Stapp (20)
and Sparky (21).
Distance and dihedral angle constraints
Interproton distances were calculated from NOESY
spectra with mixing times of 80 and 230ms, as described
previously (15–17,22), using the H20–H30 distance, which
is almost constant for any conformation, 2.2–2.3A ˚ ,a s
a reference. In total, 1054 distance constraints were
obtained for a dimer.
Dihedral angle constraints for the d, and endocyclic
n0, n1, n2, n3 and n4 torsion angles were derived from the
3JH10–H20 and
3JH30–H40 couplings (23,24), as described pre-
viously (15–17,22). The sugar pucker was determined as
follows on the basis of the results of analysis of the
intensities of the H10–H20 and H30–H40 cross-peaks in
the DQF-COSY spectrum: the C20-endo conformation
for the G1, G2, G5, A6, G7 and G8 residues, the
O40-endo conformation for the A12 residue, the C40-exo
conformation for the G11 residue and the C30-endo con-
formation for the A3, G4, A9 and G10 residues. The d and
endocyclic n0–n4 torsion angles of the residues taking on
the C20-endo conformation were moderately constrained,
leaving the sugar free to take on any conformation with-
out any energy penalty between C10-exo and C30-exo,
including C20-endo in the pseudorotation cycle. In the
same way, those of the A12 residue taking on the
O40-endo conformation were constrained between
C40-exo and C10-exo including O40-endo, those of the
G11 residue taking on the C40-exo conformation between
C30-endo and O40-endo, including C40-exo, and those of
the residues taking on the C30-endo conformation between
C20-exo and C40-exo, including C30-endo.
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Structure calculations were carried out using distance and
dihedral angle constraints with a simulated annealing
protocol supplied with XPLOR-NIH v. 2.20 (25,26).
Hydrogen-bonding constraints for G:G and G:A base
pairs of the tetrad and hexad were included. Planarity
constraints for the tetrad and hexad were also included.
The initial structure for the simulated annealing protocol
was generated byseparating two chains, each 12nt long, by
50A ˚ . After high temperature dynamics at 2000K (80000
steps with a time step of 0.001ps), the system was gradually
cooled to 100K (240000 steps with the same time step),
and then energy minimized. Ten ﬁnal structures were
selected from 200 calculations on the basis of the criterion
of the smallest residual energy values. None of them
violated the distance constraints by >0.5A ˚ or the dihedral
angle constraints by >58.
The atomic coordinates have been deposited in the
RCSB under Protein Data Bank accession code 2rqj.
Epitope mapping by ME
The Hitachi SV1210 microchip CE system (Hitachi
Electronics Engineering Co. Ltd, Tokyo, Japan) was
used for ME as described previously (27,28). The channel
was ﬁlled with 0.6% hydroxypropyl methylcellulose
(HPMC, Sigma, St Louis, MO, USA) in 1  TBE buﬀer
(89mM Tris, 89mM borate, 2mM EDTA) containing a
1:10000 dilution of TO-PRO-3 (Molecular Probes, Inc.
Carlsbad, CA, USA). The reaction mixture (10ml) was
applied to the sample well of the microchip device and
the program was run at 600V for 120s (injection time),
then at 1100V for 150s (separation time) under 350V of
return voltage at 208C. During the electric separation, the
separated RNA peaks were detected by laser induced
ﬂuorescence and analyzed.
The 12-mer peptide libraries covering bPrP 25–131 were
overlapped with a +4 position shift between consecutive
peptides (PEP screen, Sigma-Aldrich). At ﬁrst R12
(100nM) was incubated in binding buﬀer [20mM Tris–
HCl (pH 7.5), 10mM KCl] under the refolding condition:
908C for 2min, 728C for 5min, 558C for 5min, 378C for
2min and kept at 48C. Following the addition of
Cy5-dUTP (10nM, Amersham Biosciences), the internal
standard, the RNA solution was incubated with peptides
(0, 100mM) for 15min and analyzed using ME. The
observed peak intensity of R12 was divided with
the peak intensity of the internal standard, which gives
the relative peak intensity. The value of the relative peak
intensity of R12 was normalized by dividing the relative
peak intensity of R12 in the absence of peptide, giving the
normalized peak intensity. The relative binding of R12
was deﬁned by the number [1–(the normalized peak
intensity)] and plotted for each peptide. Experiments
were performed at least twice.
RESULTS
Resonance assignments
Figure 1B shows the base region of a JR-HMBC
spectrum. An adenine base gives four correlation peaks,
H2-C4, H8-C4, H2-C6 and H8-C5. It should be noted that
the H2-C4, H8-C4 and H2-C6 correlation peaks are
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Figure 1. NMR spectra for resonance assignments at 308C. The imino (A) and base (B) regions of the JR-HMBC spectrum, being recorded with the
13C spectral width of 40p.p.m. The H2-C4, H8-C4, H2-C6 and H8-C5 correlation peaks for each adenine, and the H8-C4 and H8-C5 ones for each
guanine are connected by lines, respectively, in (B). The NH (imino proton)-C5 correlation peak in (A) and the H8-C5 in (B) for each guanine are
connected by a horizontal line. (C) The ﬁngerprint region of the NOESY spectrum with the mixing time of 150ms. The H10 (i-1)-H6/H8(i)-H10 (i)
connectivities are traced, intraresidue cross-peaks being denoted by residue numbers. Dots indicate cross-peaks that are observable when the contour
level is lowered.
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mental spectral width, along the
13C dimension. Among
them, the H2-C4 and H8-C4 correlation peaks for each
adenine are aligned horizontally at the
13C chemical shift
value of C4 of each adenine. Conversely, the H2-C4 and
H2-C6 correlation peaks, and H8-C4 and H8-C5 ones are
aligned vertically, respectively. Thus, a set of resonances
for each adenine was identiﬁed. A guanine base gives two
correlation peaks, H8-C4 and H8-C5, which are aligned
vertically (Figure 1B). The H8-C4 correlation peak is
also folded back along the
13C dimension. Thus, a set of
resonances for each guanine was also identiﬁed. With the
aid of the knowledge on discrimination between adenine
and guanine resonances, the sequential assignment of
the ﬁngerprint region was accomplished (Figure 1C).
The other nonexchangeable
1H resonances were assigned
using standard methods (17), as described for other DNAs
and RNAs (15–17,22,29), by means of NOESY, TOCSY
and DQF-COSY spectra. Figure 1A shows the NH (imino
proton)-C5 correlation peaks for each guanine base. The
NH-C5 correlation peak is aligned horizontally with the
H8-C5 one for each guanine base at the
13C chemical shift
value of C5. On the basis of the assignment of H8, NH
was assigned for eight guanines. NH2 (amino proton)
resonances were assigned on the basis of the strong
imino–amino NOESY cross-peaks.
Identification of the G:G:G:G tetrad and
G(:A):G:G(:A):G hexad planes
The observation of GNH (imino proton)/GNH2 (amino
protons)-GH8 and GNH-GNH NOESY cross-peaks
(Figure 2A and B) established the formation of
G:G:G:G tetrad planes for G2:G5:G8:G11 and G1:G4:
G7:G10 (Figure 2C and D). For the latter tetrad, the fur-
ther involvement of two adenine bases, A3 and A9, and
the resultant formation of a G(:A):G:G(:A):G hexad plane
(Figure 2D) was concluded on the basis of the GNH/
GNH2-AH8 (Figure 2B), GNH2-ANH2, GH8-AH8 and
GH8-ANH2 NOEs. It was noted that the two amino
protons both resonated in the low-ﬁeld region for the
G1 (8.87 and 10.56p.p.m.) and G7 (8.99 and 10.15
p.p.m.) residues, while only one of them did so for the
other G residues. This is consistent with the idea that
both the amino protons are involved in hydrogen bonding
for G1 and G7, while only one of them is involved for the
other G residues (Figure 2C and D).
Dimer architecture
We reported that d(GGAGGAGGAGGA) (D12) forms a
dimer in which the G(:A):G(:A):G(:A):G heptad plane of
one monomer stacks on the heptad plane of the other.
The H/D exchange experiment indicated that the imino
protons of the G1, G4, G7 and G10 residues survive in
D2O (Figure 2H). This strongly suggests that R12 also
forms a dimer in which the G1(:A3):G4:G7(:A9):G10
hexad plane of one monomer stacks on the hexad plane
of the other and that thus imino protons belonging to the
hexad are protected from access to and exchange with
solvent water molecules (Figure 2F). This dimeric archi-
tecture was conﬁrmed by the observation of strong
A3H2-A3H10 and A9H2-A9H10 NOESY cross-peaks
(Figure 2G). The intraresidue AH2-AH10 distance is
>4.5A ˚ for any conformation (30). Therefore, the
A3H2-A3H10 and A9H2-A9H10 NOESY cross-peaks
cannot be an intraresidue ones, but they should be
between the two monomers, which is consistent with the
architecture described above. Then, the following NOESY
cross-peaks were identiﬁed to support the architecture;
A3H2-A3H20, A3H2-A3H30, A3H2-A3H8, A3NH2-
A3H8, A9H2-A9H20, A9H2-A9H30, A9H2-A9H8 and
A9NH2-A9H8. Moreover, eight NOESY cross-peaks
between G1 and G4 residues and ten NOESY cross-
peaks between G7 and G10 residues were also found to
be consistent with the architecture.
Structure of R12
The structure of R12 was calculated on the basis of dis-
tance and dihedral angle constraints. The structure
statistics are presented in Table 1. The root mean square
deviations (RMSDs) of the 10 ﬁnal structures versus the
mean structure for all heavy atoms, the terminal A12
residues being excluded, were 0.48 0.07A ˚ . The structure
of R12 is shown in Figure 3. One tetrad and one hexad
planes are present for each monomer, as already described
qualitatively. The stacking between the tetrad and hexad
planes is shown in Figure 3C. The ﬁve-membered ring
of one guanine base is stacked on the six-membered ring
of the other guanine base for each G-G segment.
Additionally, the A3 and A9 bases are stacked on the
G2 and G8 sugars, respectively (Figure 3C), which is con-
sistent with the upﬁeld shift of H40 for G2 (3.13p.p.m.)
and G8 (3.07p.p.m.). Furthermore, the A12 base stacks
on the G11 base. The sugar-phosphate main-chain
experiences successive turns, and four G-G segments, i.e.
G1-G2, G4-G5, G7-G8 and G10-G11, are aligned parallel
to each other. The two monomers form a dimer in a tail-
to-tail manner through hexad–hexad stacking interaction.
The stacking of the two hexad planes is shown in
Figure 3D. The G1, A3, G4, G7, A9 and G10 bases of
one hexad plane are stacked on the G4, A3, G1, G10, A9
and G7 bases of the other hexad plane, respectively.
Comparison of the structures of R12 and D12
The structures of R12 and D12 are schematically shown in
Figure 4. Similarities can be seen between them. One R12
strand forms a quadruplex with four G-G segments
aligned parallel to each other, as one D12 strand does.
The two R12 quadruplexes form a dimer in a tail-to-tail
manner, as the two D12 quadruplexes do. Diﬀerences can
also be noted between the two structures. The R12
quadruplex comprises a G(:A):G:G(:A):G hexad plane
in addition to a G:G:G:G tetrad plane, while the D12
quadruplex comprises a G(:A):G(:A):G(:A):G heptad
plane in addition to a G:G:G:G tetrad plane. This diﬀer-
ence shows that A6 of R12 is not involved in the plane,
while that of D12 is. Moreover, the dyad axis correlating
two monomers is along the A3-A9 direction for R12, but
is perpendicular to the A3-A9 direction for D12. The
origins of these diﬀerences are discussed later.
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Figure 2. The G:G:G:G tetrad and G(:A):G:G(:A):G hexad planes, and the dimeric architecture of R12. NH (imino)-NH (A) and NH-H8
(B) cross-peaks in the NOESY spectrum with the mixing time of 230ms at 308C. Cross-peaks are denoted by mutual residue numbers. In (A),
the cross-peaks between the tetrad and hexad planes are underlined, and the intermolecular one between two hexad planes is double-underlined,
respectively. In (B), the cross-peaks as to G:A base pairs are underlined, and those between the tetrad and hexad planes are double-underlined,
respectively. The G:G:G:G tetrad (C) and G(:A):G:G(:A):G hexad (D) planes identiﬁed for R12. The observed NOESY cross-peaks are indicated
by lines. Hydrogen bonds are indicated by dotted lines. (E) The G(:A):G(:A):G(:A):G heptad plane found in D12 (15) is shown for reference.
(F) The dimeric architecture of two R12 parallel quadruplexes formed in a tail-to-tail manner through hexad-hexad stacking. (G) Intermolecular
A3H2-A3H10 and A9H2-A9H10 NOESY cross-peaks conﬁrming the dimeric architecture. (H) Imino proton spectra in H2O (upper) and D2O (lower)
at 308C with the assignments.
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It was found that the RNA aptamer comprising the
R12 sequence binds to the 25–131 region of bPrP (12).
In order to exactly identify the sites of bPrP involved in
the binding to R12, the aﬃnity of a series of 12-mer pep-
tide fragments of bPrP for R12 was examined by means
of ME (Figure 5). Four peptide fragments, peptides 1, 15,
16 and 17, exhibited high aﬃnity to R12. Peptide 1
corresponds to the ﬁrst lysine cluster of bPrP, and three
consecutive peptides 15–17 to the second lysine cluster,
respectively. Peptide 16 exhibited the highest aﬃnity.
Thus, two lysine clusters of bPrP were identiﬁed as the
binding sites for R12.
DISCUSSION
Several RNA aptamers against PrP have been isolated.
No 3D structure has been reported for these aptamers.
This study revealed the 3D structure of an RNA aptamer
against PrP for the ﬁrst time. It has been proposed for
some of these RNA aptamers that the G-quadruplex
structure plays a critical role in the binding of PrP
(4,31). For these aptamers, antiparallel quadruplexes
have been postulated. The quadruplex structure of R12,
the minimized RNA aptamer, turns out to be quite diﬀer-
ent from the postulated structures. One R12 molecule
folds into an intramolecular parallel quadruplex with a
G:G:G:G tetrad plane and a G(:A):G:G(:A):G hexad
plane. Then, two R12 molecules dimerize in a tail-to-tail
manner through intermolecular hexad–hexad stacking.
This unique structure of R12 may be utilized to bind
PrP, as discussed later.
Two major diﬀerences are noted between the R12 and
D12 structures. First, the position of the A6 residue is
diﬀerent between them. The A6 residue of R12 is located
close to the G(:A):G:G(:A):G hexad plane, but is not
linked to the hydrogen bonding network of the hexad
plane (Figures 3B and 4A). On the contrary, the A6 resi-
due of D12 is linked to the hexad plane through the
G4NH2-A6N7 and G4N3-A6NH2 hydrogen bonds,
resulting in the formation of a G(:A):G(:A):G(:A):G
heptad plane (15) (Figures 2E and 4B). A6 of R12 takes
on the C20-endo sugar conformation, while that of D12 is
C30-endo. This diﬀerence in the sugar conformation may
be related to the diﬀerent positioning of A6. Another re-
markable diﬀerence is that the w angle of the A6 residue
around the glycoside bond is approximately from +50 to
+908 for R12, while it is nearly –908 for D12 (15). Thus,
the A6 base of R12 is rotated around the glycoside bond
by  1808 compared to that of D12. This rotation of the
A6 base is also partly responsible for the diﬀerent
positioning of A6 and the nonformation of the hexad
plane for R12. The direct driving force that causes the
diﬀerences in local structure, particularly for A6 between
R12 and D12, is not clear, although it must be related to
the ribose/deoxyribose diﬀerence. A6 may preferably form
the hydrogen bond involving 20OH of either A6 or other
residues, although this is not established at this moment.
Second, the position of the dyad correlating two
monomers is diﬀerent, the two dyad axes of each structure
being perpendicular to each other. This diﬀerence can be
rationalized from the viewpoint of the maximum stacking
interaction between the two monomers. In order to
achieve the maximum stacking between two heptad
planes, two monomers should be arranged as shown in
Figure 4B. All seven bases have their stacking partners
in Figure 4B; G1 of the upper monomer stacks on G10
of the lower monomer, A3 on A9, and so on. In the case
of the other arrangement, the stacking would be less.
For example, if the lower monomer is rotated by 908 in
an anticlockwise direction around a vertical axis passing
through the center of the heptad plane, then the A3 bases
of both the upper and lower monomers would lose their
stacking partners. Similarly, if the lower monomer is
rotated by 1808, then the A6 bases of both the upper
and lower monomers would lose their stacking partners.
On the contrary, the maximum stacking between two
hexad planes can be achieved in two ways. One way is
as shown in Figure 4A. All six bases have their stacking
partners in Figure 4A; G1 of the upper monomer stacks
on G4 of the lower monomer, A3 of the upper monomers
on A3 of the lower monomer, and so on (Figures 3D and
4A). The maximum stacking is also achieved when the
lower monomer is rotated by 1808 around a vertical axis
passing through the center of the hexad. All six bases have
their stacking partners also in the resulting arrangement;
G1 of the upper monomer stacks on G10 of the lower
Table 1. NMR constraints and structural statistics for R12
NMR constraints
Distance constraints 1054
Intraresidue distance constraints 440
Sequential (i, i+1) distance constraints 298
Medium to long range   (i, i+2)
distance constraints
212
Interstrand distance constraints 104
Dihedral angle constraints 144
d 24
n0–n4 120
Planarity constraints for tetrad and hexad planes 4
Hydrogen-bonding constraints 80
Structural statistics for 10 ﬁnal structures
X-PLOR energies (kcal/mol)
Etotal 267 1
Ebond 10 0
Eangle 199 1
Eimproper 16 0
Evdw 6 0
Enoe 21 1
Ecdih 3 0
RMSD from idealized geometry
Bond lengths (A ˚ ) 0.003 0.000
Bond angles (8) 0.91 0.01
Impropers (8) 0.38 0.00
NOE violations
Number of violations >0.5A ˚ 0 0
RMSD of violations (A ˚ ) 0.019 0.000
Dihedral angle violations
Number of violations >58 0 0
RMSD of violations (8) 0.62 0.03
RMSD of 10 ﬁnal structures versus mean
structure for all heavy atoms (A ˚ )
(terminal residues excluded)
0.48 0.07
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position of the dyad axis is the same as that for D12 in
Figure 4B. Thus, for R12, two positions are equally
allowed for the dyad axis in terms of achieving the max-
imum stacking interaction between the two hexad planes;
one is as actually found for R12 and the other is as found
for D12. Then, why is the former favored for R12? In the
case of the latter position of the dyad, the A6 residues of
both the upper and lower monomers are located on the
same side, which may result in unfavorable steric hin-
drance between them. In fact, such steric hindrance is
predicted from inspection of the determined monomer
structure of R12. Conversely, in the case of the former
position of the dyad, the two A6 residues are located
away on the opposite side, resulting in no steric hindrance
between them. This could be why the former position of
the dyad is favored for R12 over the latter one. In this
way, the diﬀerence in the position of the dyad between
G10
G4
G7
A3
A9
G1
G4
G10
G7
A3
A9
G1
G8
G4
A3
G5
G7
G10
A9
G1 G11
G2
A6 A6
B
CD
A
Figure 3. The structure of R12. (A) A stereoview of the superposition of 10 ﬁnal structures of R12. The monomers are colored red and blue,
respectively, phosphate groups being colored green. (B) A stereoview of the representative structure with the lowest energy. The A6 residues of each
monomer are colored magenta and cyan, respectively. The chains connecting the C30 and C40 atoms of residues of each monomer are indicated by
red and blue tubes, respectively. (C) Stacking between the tetrad (yellow) and hexad (red) planes of the upper monomer of the representative
structure. (D) Stacking between the two hexad planes (red and blue) of each monomer of the representative structure.
Nucleic Acids Research, 2009,Vol.37, No. 18 6255R12 and D12 can be rationally explained on the basis of
the fact that the heptad is formed for D12, while the hexad
is formed instead for R12. It is interesting to note that r(G
GAGGUUUUGGAGG) adopts the same fold as R12
does (17). Two strands of this RNA form a quadruplex
dimer composed of two G:G:G:G tetrad planes and two
G(:A):G:G(:A):G hexad ones (17). This RNA cannot
form the heptad, because it has only two A residues per
a strand. The fold of R12 may be generally found for the
quadruplex composed of the tetrad and hexad planes.
It was found that the binding sites of bPrP for R12 are
two lysine clusters (Figure 5). The ﬁrst lysine cluster
comprises three lysine residues, K25, K26 and K29, and
the second one comprises four lysine residues, K112,
K115, K117 and K121. The electrostatic interaction
between the positive charges of the lysine clusters and
the negative charges of the phosphate groups of R12
must be the main factor for the high aﬃnity between
bPrP and R12. The aﬃnity of the second lysine cluster
to R12 is higher than that of the ﬁrst lysine cluster
(Figure 5). It was reported that two lysine clusters of
ovine PrP (residues 25–34 and 102–110, respectively) are
primary binding sites of the anti-ovine RNA aptamer and
that the ﬁrst lysine cluster is the major binding site (32).
These lysine clusters correspond to residues 25–34 and
110–118 of bPrP. Thus, although the two lysine clusters
are the RNA aptamer binding sites for both bPrP and
ovine PrP, the major binding sites are reversed for the
two PrPs. Because of the formation of the remarkable
quadruplex structure, the arrangement of the negatively
charged phosphate groups of R12 is unique and quite
diﬀerent from those of canonical structures such as an
A-form duplex (Figure 3B). Moreover, the density of the
negative charges is high for the R12 structure. The unique
arrangement and condensation of negative charges
exhibited by the R12 structure are supposed to be respon-
sible for high aﬃnity of R12 to bPrP through an electro-
static interaction.
It was suggested for the ovine PrP-aptamer system that
the stacking interaction of the aptamer with a tryptophan
residue may also contribute to the binding (32). The ﬁrst
and second lysine clusters of bPrP also comprise trypto-
phan residues, W34 and W110, respectively (Figure 5).
R12 has two G:G:G:G tetrad planes at the top and
bottom of its dimer structure. These planes are suitable
for the stacking interaction with the tryptophan residues.
It is notable that the aﬃnity to R12 of peptide
16 comprising three lysine residues and one tryptophan
residue is higher than that of peptide 17 comprising four
lysine residues (Figure 5). This suggests that W110 of
Figure 5. Identiﬁcation of the interaction sites on bPrP for R12.
(A) The amino acid sequences of a series of peptide fragments
of bPrP. (B) The plot of the relative binding of R12 with a series of
12-mer peptides covering bPrP 25–131. Amino acid positions 60–88
of bPrP is composed of the four repeats of peptides 10 and 11
(octapeptide repeat region).
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Figure 4. Comparison of the structures of R12 and D12. Schematic
representation of the R12 structure (this study) (A) and the D12 struc-
ture (15) (B). A dyad axis correlating the two monomers is indicated
for each structure.
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peptide 17. When the W110 residue of peptide 16 was
replaced by an alanine residue, the aﬃnity to R12
decreased to 39% of that of the original peptide 16. This
conﬁrms the importance of the contribution of W110 to
binding. When the W34 of the peptide 1 was replaced by
an alanine residue, the aﬃnity decreased to 78% of that of
the original peptide 1. This suggests that W34 also
contributes to binding to certain extent. In the case of
the antiparallel quadruplex, either a diagonal or lateral
loop passes over or below the tetrad plane and covers a
part of the tetrad plane. The remarkable point of the par-
allel quadruplex structure of R12 is that neither a diagonal
nor lateral loop passes over or below the G:G:G:G tetrad
plane. Therefore, it is supposed to be easy for a trypto-
phan residue to approach and stack on the tetrad plane of
R12, although A12 stacks on G11 and partly covers the
tetrad plane. This may be related to the high aﬃnity of
R12 for bPrP. The detailed mode of electrostatic and
stacking interactions in the ovine PrP–aptamer system
has not been addressed, because the structure of an
aptamer against ovine PrP has not been determined.
The structural determination of R12 has enabled us
to rationally interpret the contribution of electrostatic
and stacking interactions to the high aﬃnity for the
bPrP–R12 aptamer system.
It was revealed that the 25–241 region of bPrP
comprising both the ﬁrst and second lysine clusters
binds to an aptamer much more strongly than the
102–241 region comprising only the second lysine cluster
(12). This indicates that the addition of the ﬁrst lysine
cluster dramatically increases the aﬃnity, although the
aﬃnity of the ﬁrst lysine cluster is lower than that of the
second lysine cluster. These results strongly suggest that
the two lysine clusters of bPrP are simultaneously bound
by one R12 dimer molecule, resulting in the much higher
aﬃnity. From this point of view, dimer formation of R12
may contribute to the high aﬃnity by presenting two bind-
ing sites to bPrP.
So far, the structural study of R12 in complex with a
whole prion protein is not feasible due to low solubility of
the complex. The aﬃnity of either peptide 1 or peptide 16
to R12 seems to be lower than that of a whole prion pro-
tein by two orders. This may be due to the reason that a
whole protein would be bound at two diﬀerent regions by
the R12 dimer, as discussed above. Although it is neces-
sary to further examine whether the peptides are an
adequate model for PrP association, the structural study
of R12 in complex with peptides is expected to give
important information.
Judging from available structures of PrP
C (33–37), the
second lysine cluster as well as the ﬁrst one is supposed
to be exposed to the solvent for bPrP
C. Conversely, the
second lysine cluster may partly be involved in the b-sheet
structure of bPrP-b, because this cluster locates close to
the short b-sheet structure of bPrP
C and the extension
of the b-sheet structure is assumed for bPrP-b. In this
case, the access and binding of the aptamer to this clus-
ter would be hindered to some extent. This may explain
why R12 binds 30 times more strongly to bPrP
C than to
bPrP-b (12).
The binding of D12 to bPrP is weaker than that of R12
(12). The diﬀerences in the structure between R12 and
D12, which were described above, may be responsible
for the diﬀerence in the aﬃnity, although the diﬀerence
in the chemical structure of the sugar, ribose versus
deoxyribose, may also be responsible.
It was reported that an RNA aptamer obtained against
PrP
C can reduce the de novo formation of PrP
Sc probably
through the stabilization of PrP
C, suggesting the thera-
peutic potential of the aptamer against prion diseases
(4). R12 may also reduce the de novo formation of PrP
Sc
and thus may be utilized as a therapeutic agent against
prion diseases, because it binds to PrP
C more preferably
than to PrP
Sc (12), as described and rationalized above.
Very recently, it was found that PrP
C mediates impair-
ment of synaptic plasticity by amyloid-b oligomers.
Then, it was demonstrated that anti-PrP antibodies pre-
vent the binding of amyloid-b oligomers to PrP
C and
rescue synaptic plasticity in hippocampal slices from
oligomeric amyloid-b (5). Thus, a molecule that binds to
PrP
C with high aﬃnity and speciﬁcity has great thera-
peutic potential as to Alzheimer’s disease. Therefore,
R12 may be utilized as a therapeutic agent for
Alzheimer’s disease due to its high aﬃnity and speciﬁcity
to PrP
C. The atomic coordinates of R12 provided by this
work would be useful as a starting point for designing
modiﬁcation or mutation for the further development of
R12 as a therapeutic agent.
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